Search

everythinglearnresearchcommunity

for

Search:↓

MILL molecules are unique immune proteins in mice that don't need TAP to appear on cell surfaces.

The document lists research on Pemetrexed and Cisplatin for lung cancer but doesn't give a final conclusion.

The study found that immune responses disrupt hair growth cycles, causing hair loss in alopecia areata.

Activating Notch in adult skin causes T cells and neural crest cells to gather, leading to skin issues.

Immune cells affect hair growth and could lead to new hair loss treatments.

The document concludes that computational models are useful for understanding immune responses and could improve cancer immunotherapy.

Special immune cells called Treg cells are important for maintaining and regenerating hair by activating a specific growth signal in hair stem cells.

ATIR101 improves survival in stem cell transplant patients; Australian stem cell treatment decisions are influenced by regulation changes.

A specific enzyme is essential for proper hair follicle stem cell development and healthy skin.

TNC+ fibroblasts play a key role in skin inflammation by interacting with T cells.

Researchers found a specific T cell receptor linked to severe drug reactions like Stevens-Johnson syndrome when patients take carbamazepine.

New drug targets for hair loss treatment were identified by studying cell interactions in hair follicles.

Stem cell offspring help control their parent stem cells, affecting tissue health, healing, and cancer.

Cytotoxic T cells cause hair loss in chronic alopecia areata.

Controlled delivery of specific RNA and IL-4 restored hair growth in mice with autoimmune alopecia.

People with HIV and low T cell counts have more hair and scalp problems.

Androgenetic alopecia involves immune cell disruptions, especially increased CD4+ T cells around hair follicles.

Baricitinib treatment helped reduce hair loss symptoms in mice by decreasing inflammation-related immune cells.

Assessing CD8+ T cell levels before surgery may improve vitiligo treatment outcomes.

Folliculotropic mycosis fungoides has unique molecular features and cell interactions that could guide targeted therapy.

Non-immune dermal cells dominate, epidermal cells increase after day 9, and certain immune cells persist beyond inflammation in wound-induced hair follicle regeneration.

Certain immune cells contribute to skin autoimmune diseases, and some treatments can reverse hair loss in these conditions.

Follicular mycosis fungoides can look like a B-cell lymphoma, making diagnosis difficult.

HIV patients with lower CD4 T cell counts often have more skin problems.

T-regulatory cells are important for skin health and can affect hair growth and reduce skin inflammation.

Activating TLR9 helps heal wounds and regrow hair by using specific immune cells.

The COVID-19 pandemic led to fewer patient visits, more visits by older adults, an increase in cutaneous T-cell lymphoma cases, and a rise in noncosmetic procedures at a dermatology clinic.

Dihydrotestosterone (DHT) doesn't affect rat skin cell growth, but it does change cell cycle, protein levels, and other cell functions, potentially shortening hair growth cycle.

Simvastatin helps hair regrowth in autoimmune alopecia by directly affecting T cells.

MDSC-Exo can treat autoimmune alopecia areata and promote hair regrowth in mice.